Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.
Biscarini S, Villa S, Genovese C, Tomasello M, Tonizzo A, Fava M, Iannotti N, Bolis M, Mariani B, Valzano AG, Morlacchi LC, Donato F, Castellano G, Cassin R, Carrabba M, Muscatello A, Gori A, Bandera A, Lombardi A. Biscarini S, et al. Among authors: villa s. Biomedicines. 2022 Aug 18;10(8):2002. doi: 10.3390/biomedicines10082002. Biomedicines. 2022. PMID: 36009549 Free PMC article.
Stigma at the time of the COVID-19 pandemic.
Villa S, Jaramillo E, Mangioni D, Bandera A, Gori A, Raviglione MC. Villa S, et al. Clin Microbiol Infect. 2020 Nov;26(11):1450-1452. doi: 10.1016/j.cmi.2020.08.001. Epub 2020 Aug 7. Clin Microbiol Infect. 2020. PMID: 32777361 Free PMC article. No abstract available.
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy.
Torre A, Aliberti S, Castellotti PF, Cirillo DM, Grisolia A, Mangioni D, Marchetti G, Rossotti R, Santus P, Besozzi G, Villa S, Codecasa LR; Milan TB-COVID-19 study group. Torre A, et al. Among authors: villa s. Respir Med. 2020 Dec;175:106204. doi: 10.1016/j.rmed.2020.106204. Epub 2020 Nov 6. Respir Med. 2020. PMID: 33186846 Free PMC article.
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.
Lombardi A, Viero G, Villa S, Biscarini S, Palomba E, Azzarà C, Iannotti N, Mariani B, Genovese C, Tomasello M, Tonizzo A, Fava M, Valzano AG, Morlacchi LC, Donato MF, Castellano G, Cassin R, Carrabba M, Muscatello A, Gori A, Bandera A. Lombardi A, et al. Among authors: villa s. Biomedicines. 2023 May 26;11(6):1540. doi: 10.3390/biomedicines11061540. Biomedicines. 2023. PMID: 37371635 Free PMC article.
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.
Canuti M, Monti MC, Bobbio C, Muscatello A, Muheberimana T, Baldi SL, Blasi F, Canetta C, Costantino G, Nobili A, Peyvandi F, Tettamanti M, Villa S, Aliberti S, Raviglione MC, Gori A, Bandera A; COVID-19 Network Study Group. Canuti M, et al. Among authors: villa s. Front Med (Lausanne). 2023 Sep 7;10:1260950. doi: 10.3389/fmed.2023.1260950. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37746083 Free PMC article.
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.
Lombardi A, Villa S, Colaneri M, Scaglione G, Bai F, Varisco B, Bono V, Vena A, Dentone C, Russo C, Tettamanti M, Renisi G, Viero G, Azzarà C, Mantero M, Peyvandi F, Bassetti M, Marchetti G, Muscatello A, Nobili A, Gori A, Bandera A; “COVID 19 NETWORK”. Lombardi A, et al. Among authors: villa s. J Infect Public Health. 2024 Mar;17(3):467-473. doi: 10.1016/j.jiph.2023.12.026. Epub 2024 Jan 17. J Infect Public Health. 2024. PMID: 38262085 Free article.
688 results